Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line-Reference-Cited by-同舟云学术

Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line

Published:2008 Issue:3 Volume:87 Page:168-181
ISSN:1423-0194
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Grozinsky-Glasberg Simona,Franchi Giulia,Teng Mabel,Leontiou Chrysanthia A.,Ribeiro de Oliveira Jr. Antônio,Dalino Paolo,Salahuddin Nabila,Korbonits Márta,Grossman Ashley B.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference79 articles.

1. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

2. High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects

3. Enhanced protein kinase B/Akt signalling in pituitary tumours

4. Epidermal Growth Factor Receptor Expression and Activation in Neuroendocrine Tumours

5. Perturbations of the AKT signaling pathway in human cancer

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroendocrine Neoplasms;Interdisciplinary Cancer Research;2024

2. A Woman with Bilateral Pheochromocytoma and Tuberous Sclerosis Complex;AACE Clinical Case Reports;2023-12

3. Taselisib moderates neuropathic pain through PI3K/AKT signaling pathway in a rat model of chronic constriction injury;Brain Research Bulletin;2023-07

4. Evaluating new treatments for anaplastic thyroid cancer;Expert Review of Anticancer Therapy;2022-11-02

5. Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives;Expert Review of Endocrinology & Metabolism;2022-07-13